Production of human interferon-gamma in serum-free medium. 1983

M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi

Interferon (IFN)-gamma was produced with a high yield in cultures of human peripheral mononuclear cells by combined stimulation with OK-432 and staphylococcal enterotoxin B. Human mononuclear cells cultured in serum-free medium produced several times as much IFN as those in RPMI-1640 medium containing 10% fetal bovine serum. A synergistic effect of OK-432 and staphylococcal enterotoxin B on the production of IFN-gamma was demonstrated. Ultrogel AcA54 column chromatography of crude IFN showed a single peak with an apparent molecular weight of 43,000. Our production system for human IFN-gamma offers a feasible approach to preparation of large quantities of purified IFN-gamma for structure studies, antibody production, and clinical applications.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010844 Picibanil A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity. NSC-B116209,OK-432,Picibanyl,Streptococcal OK-432,Streptococcal Preparation OK-432,NSC B116209,NSCB116209,OK 432,OK432,Streptococcal OK 432,Streptococcal OK432,Streptococcal Preparation OK 432,Streptococcal Preparation OK432
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal

Related Publications

M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
January 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
May 1979, In vitro,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
March 1982, Experimental cell research,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
November 1969, Applied microbiology,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
April 1985, Journal of immunological methods,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
January 1984, Journal of interferon research,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
September 1984, Molecular immunology,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
January 1980, Journal of immunological methods,
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
September 1981, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
M Tsujimoto, and T Tarutani, and K Ogawa, and K Akashi, and Y Okubo, and N Higashi
July 1988, Clinical allergy,
Copied contents to your clipboard!